Locally advanced head and neck squamous cell carcinoma
Clinical trials for Locally advanced head and neck squamous cell carcinoma explained in plain language.
Never miss a new study
Get alerted when new Locally advanced head and neck squamous cell carcinoma trials appear
Sign up with your email to follow new studies for Locally advanced head and neck squamous cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new drug boost radiation's power against head and neck cancer in older patients?
Disease control Stopped earlyThis phase II trial is investigating whether adding the experimental drug xevinapant to standard radiation therapy can improve outcomes for adults aged 70 and older with locally advanced head and neck cancer. Participants are randomly assigned to receive either xevinapant or a pl…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase 2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Immunotherapy-Chemo cocktail tested for head and neck cancer – early trial stopped
Disease control Stopped earlyThis early-phase trial tested whether adding the immunotherapy drug durvalumab to standard chemotherapy (docetaxel, cisplatin, and 5-FU) is safe for people with advanced head and neck cancer. Only 14 patients were enrolled before the study was stopped. The goal was to find the ri…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase 1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC